AR043620A1 - Derivados 7-imino de camptotecinas que tienen actividad antitumoral - Google Patents
Derivados 7-imino de camptotecinas que tienen actividad antitumoralInfo
- Publication number
- AR043620A1 AR043620A1 ARP040100864A ARP040100864A AR043620A1 AR 043620 A1 AR043620 A1 AR 043620A1 AR P040100864 A ARP040100864 A AR P040100864A AR P040100864 A ARP040100864 A AR P040100864A AR 043620 A1 AR043620 A1 AR 043620A1
- Authority
- AR
- Argentina
- Prior art keywords
- branched
- linear
- alkyl
- group
- aminophenyl
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 5
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 abstract 1
- ZYHQGITXIJDDKC-UHFFFAOYSA-N 2-[2-(2-aminophenyl)ethyl]aniline Chemical group NC1=CC=CC=C1CCC1=CC=CC=C1N ZYHQGITXIJDDKC-UHFFFAOYSA-N 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000005915 C6-C14 aryl group Chemical group 0.000 abstract 1
- 229930194542 Keto Natural products 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- NYBWUHOMYZZKOR-UHFFFAOYSA-N tes-adt Chemical class C1=C2C(C#C[Si](CC)(CC)CC)=C(C=C3C(SC=C3)=C3)C3=C(C#C[Si](CC)(CC)CC)C2=CC2=C1SC=C2 NYBWUHOMYZZKOR-UHFFFAOYSA-N 0.000 abstract 1
- 231100001274 therapeutic index Toxicity 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Los compuestos poseen actividad antitumoral y presentan un buen índice terapéutica. Se describen procedimientos para la preparación de los mismos y su uso en la preparación de medicamentos útiles en el tratamiento de tumores, infecciones virales y anti-Plasmodium Falciparum. Reivindicación 1: Compuestos de fórmula (1). Caracterizados porque: R1 es un grupo -C(R5)=N-R4, en donde R4 es un grupo fenilo, opcionalmente sustituido con uno o más grupos seleccionados entre el grupo que consiste en: halógeno, hidroxi, ceto, alquilo C1-8, alcoxi C1-8, fenilo, ciano, nitro, -NR6R7, en donde R6 y R7, iguales o diferentes entre sí, son hidrógeno, alquilo lineal o ramificado (C1-8); -S-S-(2-aminofenilo), -S-S-(4-aminofenilo), -S-(4-aminofenilo), -SCH3 y -CH2ON=C(CH3)2; R5 es hidrógeno, alquilo lineal o ramificado C1-8, alquenilo lineal o ramificado C1-8, cicloalquilo C3-10, cicloalquilo(C3-10)-alquilo lineal o ramificado (C1-8), arilo C6-14, arilo(C6-14)-alquilo lineal o ramificado (C1-8); R2 y R3, iguales o diferentes entre sí son hidrógeno, hidroxi, alcoxi lineal o ramificado C1-8; sus N1-óxidos sus isómeros simples, en particular los isómeros sin y anti del grupo -C(R5)=N-R4, sus posibles enantiómeros, diastereoisómeros y mezclas relacionadas, las sales farmacéuticamente aceptables de los mismos y sus metabolitos activos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/388,587 US7105492B2 (en) | 1999-03-09 | 2003-03-17 | Camptothecin derivatives having antitumor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043620A1 true AR043620A1 (es) | 2005-08-03 |
Family
ID=33029646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040100864A AR043620A1 (es) | 2003-03-17 | 2004-03-16 | Derivados 7-imino de camptotecinas que tienen actividad antitumoral |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7105492B2 (es) |
| EP (1) | EP1603919B1 (es) |
| JP (1) | JP4791355B2 (es) |
| KR (1) | KR101174112B1 (es) |
| CN (1) | CN100372855C (es) |
| AR (1) | AR043620A1 (es) |
| AT (1) | ATE417851T1 (es) |
| AU (1) | AU2004222044B2 (es) |
| BR (1) | BRPI0408380A (es) |
| CA (1) | CA2517450C (es) |
| CY (1) | CY1108890T1 (es) |
| DE (1) | DE602004018468D1 (es) |
| DK (1) | DK1603919T3 (es) |
| ES (1) | ES2319293T3 (es) |
| PL (1) | PL1603919T3 (es) |
| PT (1) | PT1603919E (es) |
| SI (1) | SI1603919T1 (es) |
| TW (1) | TWI341840B (es) |
| WO (1) | WO2004083214A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105492B2 (en) * | 1999-03-09 | 2006-09-12 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Camptothecin derivatives having antitumor activity |
| ITRM20030344A1 (it) * | 2003-07-14 | 2005-01-15 | Ist Naz Stud Cura Dei Tumori | 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi. |
| ITRM20040288A1 (it) * | 2004-06-11 | 2004-09-11 | Sigma Tau Ind Farmaceuti | Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. |
| BRPI0515774A (pt) * | 2004-12-15 | 2008-08-05 | Novartis Ag | combinações de agentes terapêuticos para o tratamento de cáncer |
| US7291936B1 (en) * | 2006-05-03 | 2007-11-06 | Robson John H | Submersible electrical power generating plant |
| CN102731516B (zh) * | 2011-04-07 | 2014-07-02 | 宁波天衡药业股份有限公司 | 一类具有抗肿瘤活性的喜树碱衍生物 |
| WO2022140504A1 (en) * | 2020-12-23 | 2022-06-30 | Shanghai Ruotuo Biosciences Co., Ltd. | Antibody-drug conjugates, pharmaceutical compositions, and therapeutic applications |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399276A (en) | 1981-01-09 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | 7-Substituted camptothecin derivatives |
| JPS58154582A (ja) * | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体およびその製造法 |
| PT101061B (pt) | 1991-11-15 | 1999-07-30 | Smithkline Beckman Corp | Composicoes farmaceuticas contendo anagolos da camptotecina e um composto de coordenacao de platina e seu uso na inibicao do crescimento de celulas tumorais |
| US5614529A (en) | 1994-09-22 | 1997-03-25 | Research Triangle Institute | Inhibition of plasmodia parasites by camptothecin compounds |
| US5972955A (en) | 1995-06-06 | 1999-10-26 | Dr. Reddy's Research Foundation | Water soluble C-ring analogues of 20(S)-camptothecin |
| IT1282673B1 (it) | 1996-02-23 | 1998-03-31 | Ist Naz Stud Cura Dei Tumori | Derivati della camptotecina e loro uso come agenti antitumorali |
| AU718799C (en) | 1996-08-19 | 2004-02-12 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
| DE69901379T2 (de) | 1999-03-09 | 2002-11-07 | Istituto Nazionale Per Lo Studio E La Cura Dei Tumori, Mailand/Milano | Camptothecin-Derivate mit Antitumor-Wirkung |
| US7105492B2 (en) * | 1999-03-09 | 2006-09-12 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Camptothecin derivatives having antitumor activity |
-
2003
- 2003-03-17 US US10/388,587 patent/US7105492B2/en not_active Expired - Fee Related
-
2004
- 2004-03-04 TW TW093105744A patent/TWI341840B/zh not_active IP Right Cessation
- 2004-03-10 DE DE602004018468T patent/DE602004018468D1/de not_active Expired - Lifetime
- 2004-03-10 WO PCT/IT2004/000118 patent/WO2004083214A1/en not_active Ceased
- 2004-03-10 EP EP04719039A patent/EP1603919B1/en not_active Expired - Lifetime
- 2004-03-10 JP JP2006507637A patent/JP4791355B2/ja not_active Expired - Fee Related
- 2004-03-10 CA CA2517450A patent/CA2517450C/en not_active Expired - Fee Related
- 2004-03-10 AT AT04719039T patent/ATE417851T1/de active
- 2004-03-10 AU AU2004222044A patent/AU2004222044B2/en not_active Ceased
- 2004-03-10 PT PT04719039T patent/PT1603919E/pt unknown
- 2004-03-10 US US10/546,211 patent/US7351714B2/en not_active Expired - Fee Related
- 2004-03-10 BR BRPI0408380-6A patent/BRPI0408380A/pt not_active IP Right Cessation
- 2004-03-10 CN CNB2004800071482A patent/CN100372855C/zh not_active Expired - Fee Related
- 2004-03-10 DK DK04719039T patent/DK1603919T3/da active
- 2004-03-10 KR KR1020057015243A patent/KR101174112B1/ko not_active Expired - Fee Related
- 2004-03-10 ES ES04719039T patent/ES2319293T3/es not_active Expired - Lifetime
- 2004-03-10 PL PL04719039T patent/PL1603919T3/pl unknown
- 2004-03-10 SI SI200431027T patent/SI1603919T1/sl unknown
- 2004-03-16 AR ARP040100864A patent/AR043620A1/es not_active Application Discontinuation
-
2009
- 2009-03-17 CY CY20091100298T patent/CY1108890T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200504076A (en) | 2005-02-01 |
| CY1108890T1 (el) | 2014-07-02 |
| DK1603919T3 (da) | 2009-03-09 |
| CN100372855C (zh) | 2008-03-05 |
| US7105492B2 (en) | 2006-09-12 |
| US7351714B2 (en) | 2008-04-01 |
| SI1603919T1 (sl) | 2009-04-30 |
| CA2517450C (en) | 2011-06-14 |
| AU2004222044B2 (en) | 2010-02-25 |
| BRPI0408380A (pt) | 2006-03-21 |
| ATE417851T1 (de) | 2009-01-15 |
| US20040018988A1 (en) | 2004-01-29 |
| JP4791355B2 (ja) | 2011-10-12 |
| CA2517450A1 (en) | 2004-09-30 |
| EP1603919B1 (en) | 2008-12-17 |
| EP1603919A1 (en) | 2005-12-14 |
| PT1603919E (pt) | 2009-02-16 |
| TWI341840B (en) | 2011-05-11 |
| ES2319293T3 (es) | 2009-05-06 |
| KR20050107756A (ko) | 2005-11-15 |
| HK1089160A1 (zh) | 2006-11-24 |
| AU2004222044A1 (en) | 2004-09-30 |
| PL1603919T3 (pl) | 2009-06-30 |
| JP2006520807A (ja) | 2006-09-14 |
| US20060167033A1 (en) | 2006-07-27 |
| CN1761668A (zh) | 2006-04-19 |
| DE602004018468D1 (de) | 2009-01-29 |
| KR101174112B1 (ko) | 2012-08-16 |
| WO2004083214A1 (en) | 2004-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2170141T3 (es) | 4-aminoderivados del acido micofenolico con actividad inmunosupresora. | |
| AR063211A1 (es) | Derivados de 3-(piridin-3-il)acrilamida y 3-(piridin-3-il)propionamida, un metodo para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades asociadas con el receptor vaniloide. | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| ECSP077349A (es) | Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias | |
| EA200500018A1 (ru) | Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения | |
| ECSP024393A (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular normal | |
| ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
| PA8544901A1 (es) | Derivados de oxazol | |
| ECSP077323A (es) | Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias | |
| UY26086A1 (es) | Procedimientos e intermedios para preparar compuestos anticancerosos | |
| PE20010130A1 (es) | Derivados de 3(5)-amino-pirazol y procedimiento para su preparacion | |
| AR022860A1 (es) | Derivados de camptotecina que poseen actividad antitumoral | |
| ATE253586T1 (de) | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivat | |
| ES2168359T3 (es) | Acido micofenolico 6-sustituido y derivados con actividad inmunosupresora. | |
| PA8580301A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
| ES2069410T3 (es) | Nuevos derivados del acido hidroxamico y n-hidroxiurea y su uso. | |
| AR044045A1 (es) | Compuesto de piperidincarbonilpiperazina, composicion farmaceutica que lo comprende, su uso para la elaboracion de un medicamento y procedimiento para su preparacion | |
| PA8621901A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| ES2058450T3 (es) | Compuestos de quinoxalina y su preparacion y uso. | |
| ECSP22083772A (es) | Compuestos y composiciones para inhibir la actividad de hif2-alfa y sus métodos de uso | |
| AR043620A1 (es) | Derivados 7-imino de camptotecinas que tienen actividad antitumoral | |
| AR029461A1 (es) | Derivados de 4-fenil-1-piperazinilo, - piperidinilo y -tetrahidropiridilo , composiciones farmaceuticas que los comprenden y el uso de los mismos para la fabricacion de un medicamento | |
| AR045810A1 (es) | 6-[fenil (sustituidas) ] triazolopirimidinas como agentes anticancerosos | |
| AR042547A1 (es) | Uso de acidos alfa - feniltiocaboxilico y alfa - feniloxicarboxilico con actividad disminuidora de la glucosa en el suero y de los lipidos en el suero | |
| AR127023A1 (es) | Nuevos derivados de quinolina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |